NEPHROS INC (26)

Browse by Contract Category

Contracts

Agreement for Purchase and Sale of Assets, dated October 4, 2022, by and between Nephros, Inc. and BWSI, LLC (pursuant to Item 601(b)(2)(ii) of Regulation S-K, certain information... (Filed With SEC on November 21, 2022)
Certificate of Amendment to Amended and Restated Certificate of Incorporation of Specialty Renal Products, Inc., dated February 4, 2022 (Filed With SEC on May 5, 2022)
Separation Agreement and Release, between the Company and Daniel DAgostino, dated January 28, 2021 (Filed With SEC on May 6, 2021)
First Amendment to Series A Preferred Stock Purchase Agreement, dated February 1, 2022, among Specialty Renal Products, Inc. and the Purchaser parties identified therein (Filed With SEC on May 5, 2022)
First Amendment to Loan Agreement dated January 19, 2022, between the Company and Specialty Renal Products, Inc (Filed With SEC on May 5, 2022)
Asset Purchase Agreement between Nephros, Inc. and GenArraytion, Inc. dated July 9, 2021 (Filed With SEC on November 4, 2021)
Letter Agreement, dated November 30, 2020, between Wesley S. Lobo and the Registrant (Filed With SEC on March 1, 2021)
Letter Agreement dated September 22, 2020, between Dan DAgostino and Nephros, Inc (Filed With SEC on November 5, 2020)
Consulting Agreement between Specialty Renal Products, Inc. and Daron Evans, dated August 26, 2020 (Filed With SEC on November 5, 2020)
Consulting Agreement between the Registrant and Daron Evans, dated August 23, 2020 (Filed With SEC on November 5, 2020)
Employment Agreement between the Registrant and Andrew Astor, dated August 23, 2020 (Filed With SEC on November 5, 2020)
Second Amendment to Membership Interest Purchase Agreement, between the Company and Gregory Lucas, dated October 15, 2020 (Filed With SEC on October 20, 2020)
Form of Securities Purchase Agreement dated October 15, 2020, between Nephros, Inc. and the Purchasers (Filed With SEC on October 16, 2020)
8% Convertible Promissory Note, from Specialty Renal Products, Inc. to the Company, dated October 7, 2020 (Filed With SEC on October 13, 2020)
Loan Agreement between the Company and Specialty Renal Products, dated October 7, 2020 (Filed With SEC on October 13, 2020)
U.S. Small Business Administration Paycheck Protection Program Note dated April 22, 2020, between the Registrant and First Republic Bank (Filed With SEC on August 5, 2020)
Amended and Restated Secured Promissory Note (Single Advance Non-Revolving), dated May 26, 2020, issued by the Registrant (Filed With SEC on August 5, 2020)
Amended and Restated Loan and Security Agreement, dated May 26, 2020, by and between Tech Capital, LLC and the Registrant (Filed With SEC on August 5, 2020)
First Amendment to Membership Interest Purchase Agreement, dated June 24, 2020, by and between the Registrant and Gregory Lucas (Filed With SEC on August 5, 2020)
Description of Capital Stock (Filed With SEC on February 27, 2020)
Underwriting Agreement dated January 31, 2020, between Nephros, Inc. and Craig-Hallum Capital Group LLC (Filed With SEC on January 31, 2020)
First Modification to Loan and Security Agreement dated December 20, 2019, between Nephros, Inc. and Tech Capital, LLC (Filed With SEC on December 26, 2019)
Form of Stock Purchase Agreement, dated May 15, 2019, among Nephros, Inc. and the Purchasers identified therein (Filed With SEC on May 16, 2019)
First Amendment to Employment Agreement between Nephros, Inc. and Daron Evans, effective April 15, 2019 (Filed With SEC on May 8, 2019)
Membership Interest Purchase Agreement, dated December 31, 2018, by and among the Registrant, Biocon 1, LLC, Aether Water Systems, LLC, and Gregory Lucas (Filed With SEC on March 12, 2019)
Second Amendment to Sublicense Agreement, dated January 30, 2019, between the Registrant and CamelBak Products, LLC (Filed With SEC on March 12, 2019)